Clinical Trial Update: Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cisplatin and gemcitabine chemotherapy combined with lenvatinib for unresectable intrahepatic cholangiocarcinoma is described, with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cholangiocarcinoma, Intrahepatic | Phase 2 | Status: UNKNOWN